B. Fauser

B. Fauser, H. C. Coelingh Bennink, Y. Zimmerman, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.

E. Laan, B. Fauser, R. V. van Lunsen, 2018, Contraception.

Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients.

B. Fauser, T. J. van Dessel, E. J. V. van Santbrink, 1995, Human reproduction.

Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation.

M. Cohen, B. Fauser, F. de Jong, 1992, The Journal of clinical endocrinology and metabolism.

Cost-effectiveness of hysteroscopy screening for infertile women.

F. Broekmans, B. Fauser, R. Eijkemans, 2013, Reproductive biomedicine online.

Breast cancer risk after oocyte donation: should we really be concerned?

B. Fauser, J. G. García Velasco, 2017, Reproductive biomedicine online.

Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.

E. Anckaert, B. Fauser, F. de Jong, 2011, The Journal of clinical endocrinology and metabolism.

Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.

D. Barlow, B. Fauser, E. Bestel, 2014, Human reproduction.

Tibolone and its effects on bone: a review.

B. Fauser, H. Bennink, B. Fauser, 2001 .

Balancing the strengths of systematic and narrative reviews.

B. Fauser, J. Collins, John A Collins, 2005, Human reproduction update.

Chapter 132 – Female Infertility: Evaluation and Management

F. Broekmans, B. Fauser, 2016 .

Is bacterial vaginosis associated with a pro-inflammatory cytokine profile in endometrial secretions of women undergoing IVF?

M. Eijkemans, B. Fauser, A. Kavelaars, 2010, Reproductive biomedicine online.

Cardiovascular Risk in Women With Premature Ovarian Insufficiency Compared to Premenopausal Women at Middle Age.

O. Franco, E. Boersma, M. Kavousi, 2016, The Journal of clinical endocrinology and metabolism.

RBM online: challenges ahead in scientific publishing.

B. Fauser, 2017, Reproductive biomedicine online.

Improving the Reporting of Clinical Trials of Infertility Treatment (IMPRINT): explanation and elaboration of the modification of the CONSORT statement

K. Barnhart, C. Farquhar, B. Fauser, 2014 .

The older woman wishing to conceive

P. Devroey, B. Fauser, H. Fatemi, 2008 .

Retrieval, Maturation, and Fertilization of Immature Oocytes Obtained from Unstimulated Patients with Polycystic Ovary Syndrome

L. Ramos, B. Fauser, D. Braat, 1999, Journal of Assisted Reproduction and Genetics.

Reproductive biology and IVF: ovarian stimulation and endometrial receptivity

P. Devroey, B. Fauser, C. Bourgain, 2004, Trends in Endocrinology & Metabolism.

Sex Steroid Hormones and Reproductive Disorders

Robert N. Taylor, P. Mermelstein, P. Vercellini, 2011, Reproductive Sciences.

Female Reproductive Dysfunction

F. Petraglia, A. Lenzi, E. Jannini, 2020, Endocrinology.

Effects of gonadotropin releasing hormone agonist addition to gonadotropin induction of ovulation in polycystic ovary syndrome patients.

T. Stijnen, B. Fauser, D. Schoot, 1992, European journal of obstetrics, gynecology, and reproductive biology.

IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome--following previous unsuccessful ovulation induction.

M. Eijkemans, B. Fauser, J. Laven, 2003, Reproductive biomedicine online.

Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis.

M. Eijkemans, B. Fauser, J. Laven, 2003, Human reproduction update.

Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

L. Giudice, M. Eijkemans, B. Fauser, 2000, The Journal of clinical endocrinology and metabolism.

Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.

M. Eijkemans, F. Broekmans, H. Torrance, 2015, Fertility and sterility.

Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture.

M. Eijkemans, B. Fauser, M. Pieters, 2000, Fertility and sterility.

Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model.

B. Mol, M. Eijkemans, P. Hompes, 2011, Fertility and sterility.

Context-based infertility care.

B. Fauser, N. Macklon, Nick S. Macklon, 2019, Reproductive biomedicine online.

What role of estrogens in ovarian stimulation.

B. Fauser, J. Laven, 2006, Maturitas.

Role of estrogens in ovarian dysfunction and fertility. Options for new therapies with SERMs.

B. Fauser, J. Laven, 2004, Ernst Schering Research Foundation workshop.

Anti-Müllerian Hormone Serum Concentrations in Normoovulatory and Anovulatory Women of Reproductive

B. Fauser, J. Visser, J. Laven, 2003 .

Is there a future for ovulation induction in the current era of assisted reproduction?

B. Fauser, E. J. V. van Santbrink, E. V. van Santbrink, 2003, Human reproduction.

Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.

W. Hop, S. Lamberts, B. Fauser, 1991, The Journal of clinical endocrinology and metabolism.

L. Giudice, G. Faessen, B. Fauser, 2022 .

Reply: Why do couples drop out from IVF treatment?

B. Fauser, N. Macklon, M. Verberg, 2008 .

GnRH antagonists in ovarian stimulation for IVF.

E. Kolibianakis, B. Tarlatzis, P. Devroey, 2006, Human reproduction update.

Failures (with some successes) of assisted reproduction and gamete donation programs.

P. Crosignani, L. Gianaroli, B. Tarlatzis, 2013, Human reproduction update.

The phenotype of polycystic ovary syndrome ameliorates with aging.

Zoe Ann Brown, B. Fauser, J. Laven, 2009, Fertility and sterility.

Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

M. Jarvelin, A. Uitterlinden, T. Spector, 2019, PLoS genetics.

Functional genetic polymorphisms and female reproductive disorders: Part II—endometriosis

B. Destenaves, B. Fauser, M. Simoni, 2008, Human reproduction update.

Textbook of Obstetrics and Gynaecology

B. Fauser, C. Hilders, V. VincentW., 2019, Bohn Stafleu van Loghum.

The relation between clinical manifestations of polycystic ovary syndrome and β‐cell function

B. Fauser, R. Weber, J. Birkenhäger, 1993, Clinical endocrinology.

Premature Ovarian Insufficiency

B. Fauser, S. Luisi, L. Troìa, 2020, Endocrinology.

Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.

L. Giudice, G. Faessen, B. Fauser, 1996, The Journal of clinical endocrinology and metabolism.

M. Eijkemans, B. Fauser, J. Laven, 2001, European journal of endocrinology.

Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency.

L. Giudice, M. Eijkemans, G. Faessen, 2002, Fertility and sterility.

The fate of the mosaic embryo: chromosomal constitution and development of Day 4, 5 and 8 human embryos.

B. Fauser, D. Van Opstal, E. Baart, 2010, Human reproduction.

FISH analysis of 15 chromosomes in human day 4 and 5 preimplantation embryos: the added value of extended aneuploidy detection

B. Fauser, D. Opstal, E. Baart, 2007, Prenatal diagnosis.

Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF.

B. Fauser, R. Galjaard, D. Van Opstal, 2006, Human reproduction.

The Insulin-Like Growth Factor (IGF) System in Human Ovary and Its Relevance to Polycystic Ovarian Syndrome

L. Giudice, B. Fauser, N. Cataldo, 1996 .

Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome.

L. Giudice, B. Fauser, N. Cataldo, 1995, Progress in growth factor research.

Fibroblast growth factor inhibits luteinizing hormone-stimulated androgen production by cultured rat testicular cells.

B. Fauser, A. Hsueh, A. Baird, 1988, Endocrinology.

The step-down principle in gonadotrophin treatment and the role of GnRH analogues.

B. Fauser, P. Donderwinkel, D. Schoot, 1993, Bailliere's clinical obstetrics and gynaecology.

Pregnancy complications in women with polycystic ovary syndrome.

B. Fauser, M. Koster, S. Palomba, 2015, Human reproduction update.

Fibroblast Growth Factors as Local Mediators of Gonadal Function

B. Fauser, A. Hsueh, N. Emoto, 1989 .

Prevalence of Subclinical Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography in 45- to 55-Year-Old Women With a History of Preeclampsia.

A. Maas, A. Franx, E. Boersma, 2018, Circulation.

Preimplantation genetic screening: the end of an affair?

B. Fauser, 2008, Human reproduction.

Inhibins and adult ovarian function

B. Fauser, J. Laven, B.C.J.M. Fauser, 2004, Molecular and Cellular Endocrinology.

The Impact of Ovarian Stimulation With Recombinant FSH in Combination With GnRH Antagonist on the Endometrial Transcriptome in the Window of Implantation

L. Giudice, B. Fauser, N. Macklon, 2008, Reproductive Sciences.

Consensus on infertility treatment related to polycystic ovary syndrome (Human Reproduction (2007) 23, (462))

D. Goulis, C. Farquhar, P. Crosignani, 2008 .

Endogenous sex hormones and risk of venous thromboembolism in young women

F. Rosendaal, S. Middeldorp, B. Fauser, 2019, Journal of thrombosis and haemostasis : JTH.

Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.

P. Devroey, D. Baird, B. Fauser, 2009, Human reproduction update.

Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

E. Laan, B. Fauser, R. V. van Lunsen, 2017, Contraception.

The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome

B. Mol, F. Broekmans, B. Fauser, 2010, Current opinion in obstetrics & gynecology.

Inhibitory actions of interleukin-1 beta on steroidogenesis in primary cultures of neonatal rat testicular cells.

B. Fauser, A. Hsueh, A. Galway, 1989, Acta endocrinologica.

Diagnostic criteria for polycystic ovarian syndrome

F. Broekmans, B. Fauser, PhD F. J. Broekmans MD, 2006, Endocrine.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡

L. Redman, B. Mol, J. Qiao, 2018, Human reproduction.

Prognostic testing for ovarian reserve

F. Broekmans, B. Fauser, S. Broer, 2012 .

Incidental findings on coronary computed tomography in women with selected reproductive disorders

A. Franx, E. Boersma, B. Fauser, 2022, Insights into Imaging.

Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis.

M. Eijkemans, C. Lambalk, F. Broekmans, 2014, Fertility and sterility.

Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with rec

M. Eijkemans, B. Fauser, E. Loumaye, 2003, The Journal of clinical endocrinology and metabolism.

Ovulation induction with clomiphene or gonadotropins

J. Huirne, B. Fauser, N. Macklon, 2005 .

M. Eijkemans, B. Fauser, J. Laven, 2010, Menopause.

The association between vascular function-related genes and age at natural menopause

P. Peeters, Y. T. van der Schouw, F. Broekmans, 2008, Menopause.

The association of CGG repeats in the FMR1 gene and timing of natural menopause.

Y. T. van der Schouw, N. Onland-Moret, F. Broekmans, 2013, Human reproduction.

Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen.

B. Fauser, K. Dahl, B. Schoot, 1996, Human reproduction.

Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility.

B. Fauser, J. Laven, E. Nieschlag, 2003, Fertility and sterility.

Estrogen- but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease.

L. Giudice, B. Fauser, Y. Chandrasekher, 1995, The Journal of clinical endocrinology and metabolism.

Placental characteristics in women with polycystic ovary syndrome.

B. Fauser, P. Nikkels, B. V. van Rijn, 2015, Human reproduction.

Granulosa cell aromatase bioassay: changes of bioactive FSH levels in the female.

B. Fauser, A. Hsueh, N. Czekala, 1989, Journal of steroid biochemistry.

Hypertensive pregnancy complications in poor and normal responders after in vitro fertilization.

F. Broekmans, B. Fauser, R. Eijkemans, 2010, Fertility and sterility.

Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility.

A. Uitterlinden, C. Lambalk, B. Fauser, 2015, Fertility and sterility.

Limited contribution of NR5A1 (SF-1) mutations in women with primary ovarian insufficiency (POI).

W. Kloosterman, J. Giltay, B. Fauser, 2012, Fertility and sterility.

Long-term treatment of uterine fibroids with ulipristal acetate ☆.

I. Osterloh, D. Barlow, B. Fauser, 2014, Fertility and sterility.

Long-term treatment of uterine fi broids with ulipristal acetate *

D. Barlow, B. Fauser, P. Bouchard, 2022 .

Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome.

B. Fauser, P. ten Hacken, F. Rommerts, 1997, The Journal of clinical endocrinology and metabolism.

Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.

P. Devroey, B. Fauser, A. Mulders, 2004, The Journal of clinical endocrinology and metabolism.

Insulin-like growth factor binding protein-2, 28 kDa and 24 kDa insulin-like growth factor binding protein levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries

E. Zwarthoff, B. Fauser, S. Drop, 1993, Regulatory Peptides.

Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo.

M. Eijkemans, B. Fauser, A. Kavelaars, 2010, Fertility and sterility.

Cell Lineage Specific Distribution of H3K27 Trimethylation Accumulation in an In Vitro Model for Human Implantation

S. M. Chuva de Sousa Lopes, B. Fauser, N. Geijsen, 2012, PloS one.

Management of infertility in a patient presenting with ovarian dysfunction and McCune-Albright syndrome.

B. Fauser, J. Laven, S. Lumbroso, 2004, The Journal of clinical endocrinology and metabolism.

CLINICAL CASE SEMINAR Dynamics of Ovarian Function in an Adult Woman with McCune-Albright Syndrome*

B. Fauser, J. Laven, S. Lumbroso, 2001 .

Dynamics of ovarian function in an adult woman with McCune--Albright syndrome.

B. Fauser, J. Laven, S. Lumbroso, 2001, The Journal of clinical endocrinology and metabolism.

Reproductive medicine : molecular, cellular and genetic fundamentals

B. Fauser, 2003 .

Residual ovarian activity during oral steroid contraception.

B. Fauser, B. Fauser, A. V. van Heusden, 2002, Human reproduction update.

FSH and ovarian response: spontaneous recovery of pituitary–ovarian activity during the pill‐free period vs. exogenous recombinant FSH during high‐dose combined oral contraceptives

B. Fauser, H. C. Coelingh Bennink, B. Fauser, 2002, Clinical endocrinology.

Therapy: Unexplained infertility — ongoing transatlantic debate

B. Fauser, 2016, Nature Reviews Endocrinology.

European Society of Human Reproduction and Embryology ( ESHRE ) Annual Meeting in Barcelona , Spain Chairperson :

B. Fauser, J. Havelock, E. Labarta, 2018 .

Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.

M. Eijkemans, F. Broekmans, H. Torrance, 2015, Human reproduction.

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

P. De Sutter, B. Fauser, M. Fernández-Sánchez, 2014, Fertility and sterility.

Patient-Tailored Approaches to Ovarian Stimulation in ART

F. Broekmans, H. Torrance, B. Fauser, 2013 .

Mild versus standard in-vitro fertilisation techniques – Authors' reply

B. Fauser, N. Macklon, E. Heijnen, 2007, The Lancet.

Gonadotrophins in ovulation induction.

B. Fauser, N. Macklon, 2005, Reproductive biomedicine online.

Preimplantation aneuploidy screening: a research tool for now

P. Devroey, B. Fauser, 2007, The Lancet.

Aspects of Ovarian Follicle Development throughout Life

B. Fauser, N. Macklon, Nick S. Macklon, 2000, Hormone Research in Paediatrics.

Autonomy and self-esteem of women who donate to an oocyte cryopreservation bank in the Netherlands.

A. Bredenoord, B. Fauser, J. Maas, 2017, Reproductive Biomedicine Online.

Fertility and ovarian function in high-dose estrogen-treated tall women.

A. V. van Ginneken, B. Fauser, J. Visser, 2011, The Journal of clinical endocrinology and metabolism.

B. Fauser, F. de Mora, B. Fauser, 2017, Reproductive biomedicine online.

Chromosome segregation regulation in human zygotes: altered mitotic histone phosphorylation dynamics underlying centromeric targeting of the chromosomal passenger complex.

S. Lens, B. Fauser, J. Laven, 2015, Human reproduction.

In vitro fertilization pregnancy in a patient with proven chronic endometritis.

P. Devroey, B. Fauser, C. Bourgain, 2009, Fertility and sterility.

Contemporary Pharmacological Manipulation in Assisted Reproduction

J. Huirne, C. Lambalk, P. Hompes, 2012, Drugs.

What constitutes a reasonable compensation for non-commercial oocyte donors: an analogy with living organ donation and medical research participation

A. Bredenoord, B. Fauser, R. van der Graaf, 2019, Journal of Medical Ethics.

Ethics of oocyte banking for third-party assisted reproduction: a systematic review

A. Bredenoord, B. Fauser, R. van der Graaf, 2018, Human reproduction update.

Fertility and ageing.

L. Gianaroli, B. Tarlatzis, P. Devroey, 2005, Human reproduction update.

The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.

M. Eijkemans, F. Broekmans, B. Fauser, 2008, Human reproduction update.

Beliefs, attitudes and funding of assisted reproductive technology: Public perception of over 6,000 respondents from 6 European countries

B. Tarlatzis, J. Boivin, B. Fauser, 2019, PloS one.

Ovarian aging: mechanisms and clinical consequences.

F. Broekmans, B. Fauser, M. Soules, 2009, Endocrine reviews.

The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women.

M. Eijkemans, P. Devroey, P. Platteau, 2006, European journal of endocrinology.

Who will conceive with IVF?

B. Fauser, N. Macklon, 2006 .

Europe the continent with the lowest fertility.

P. Crosignani, L. Gianaroli, W. Lutz, 2010, Human reproduction update.

Fair allocation of cryopreserved donor oocytes: towards an accountable process.

A. Bredenoord, B. Fauser, R. van der Graaf, 2021, Human reproduction.

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial.

M. Eijkemans, B. Fauser, D. Van Opstal, 2007, Human reproduction.

Access to ART treatment and gender equality.

B. Fauser, G. Chambers, 2021, Reproductive biomedicine online.

Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?

B. Fauser, J. Visser, F. de Jong, 2008, Reproductive biomedicine online.

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

Jan Passchier, Suzanne Polinder, S. Polinder, 2007, The Lancet.

Social egg freezing: Who chooses and who uses?

B. Fauser, G. Lockwood, 2018, Reproductive biomedicine online.

Tackling burden in ART: an integrated approach for medical staff.

J. Boivin, B. Fauser, C. Verhaak, 2012, Human reproduction.

A bright future.

Martin H. Johnson, B. Fauser, J. García-Velasco, 2017, Reproductive biomedicine online.

Towards the global coverage of a unified registry of IVF outcomes.

B. Fauser, 2019, Reproductive biomedicine online.

Pre-Conception Characteristics Predict Obstetrical and Neonatal Outcomes in Women With Polycystic Ovary Syndrome

G. Bonsel, M. Eijkemans, C. Meun, 2018, The Journal of clinical endocrinology and metabolism.

Intraovarian control of early folliculogenesis.

Yuan Cheng, B. Fauser, A. Hsueh, 2015, Endocrine reviews.

Primary ovarian insufficiency

P. Devroey, B. Fauser, M. Vos, 2010, The Lancet.

First birth following spindle transfer for mitochondrial replacement therapy: hope and trepidation.

Martin H. Johnson, J. Simpson, B. Fauser, 2017, Reproductive biomedicine online.

Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis.

I. Izhaki, B. Fauser, J. Younis, 2020, Human reproduction update.

An endometrial gene expression signature accurately predicts recurrent implantation failure after IVF

Marinus J. C. Eijkemans, F. Holstege, M. Eijkemans, 2016, Scientific Reports.

Stakeholders views on the ethical aspects of oocyte banking for third-party assisted reproduction: a qualitative interview study with donors, recipients and professionals

A. Bredenoord, B. Fauser, R. van der Graaf, 2019, Human reproduction.

Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?

P. Devroey, B. Fauser, 2005, Fertility and sterility.

Anti-Müllerian hormone and ovarian dysfunction

F. Broekmans, B. Fauser, J. Visser, 2008, Trends in Endocrinology & Metabolism.

Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility.

M. Eijkemans, B. Fauser, B. Imani, 2003, Reproductive biomedicine online.

Economic evaluation of the administration of follitropin-β with a pen device

K. Bruynesteyn, P. Devroey, B. Fauser, 2005 .

Child development and quality of parenting in lesbian families: no psychosocial indications for a-priori withholding of infertility treatment. A systematic review.

J. Passchier, B. Fauser, J. Hunfeld, 2002, Human reproduction update.

Multiple birth resulting from ovarian stimulation for subfertility treatment

P. Devroey, B. Fauser, N. Macklon, 2005, The Lancet.

Follicle development during the normal menstrual cycle.

B. Fauser, N. Macklon, Nick S. Macklon, 1998, Maturitas.

The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.

H. Teede, R. Norman, E. Stener-Victorin, 2016, Human reproduction update.

Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort

M. Eijkemans, F. Meijboom, C. Uiterwaal, 2018, Reproductive Sciences.

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.

M. Eijkemans, B. Fauser, G. Visser, 2006, Human reproduction update.

Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature.

H. Delemarre-van de Waal, P. Devroey, M. Bonduelle, 2014, Reproductive biomedicine online.

Alternative approaches in IVF.

P. Devroey, A. V. Van Steirteghem, B. Fauser, 2002, Human reproduction update.

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

M. Eijkemans, F. Broekmans, B. Fauser, 2011, The Journal of clinical endocrinology and metabolism.

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

B. Fauser, J. Visser, J. Laven, 2004, Molecular human reproduction.

Consensus on infertility treatment related to polycystic ovary syndrome

D. Goulis, P. Crosignani, E. Kolibianakis, 2008 .

Observer agreement in the evaluation of the uterine cavity by hysteroscopy prior to in vitro fertilization.

M. Eijkemans, P. Devroey, F. Broekmans, 2011, Human reproduction.

Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization.

P. Devroey, F. Broekmans, B. Fauser, 2010, Human reproduction.

Normal human follicle development: an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles

B. Fauser, F. de Jong, T. Pache, 1996, Clinical endocrinology.

Impact of ovarian hyperstimulation on the luteal phase.

B. Fauser, N. Macklon, B. Fauser, 2000, Journal of reproduction and fertility. Supplement.

Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction.

P. Arck, F. Petraglia, H. Tournaye, 2019, Reproductive biomedicine online.

BIOACTIVE AND IMMUNOREACTIVE FSH IN SERUM OF NORMAL AND OLIGOSPERMIC MEN

W. Hop, B. Fauser, F. H. Jong, 1990, Clinical endocrinology.

Granulosa cells as hormone targets: the role of biologically active follicle-stimulating hormone in reproduction.

B. Fauser, A. Hsueh, T. Bicsak, 1989, Recent progress in hormone research.

In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines.

B. Fauser, A. Hsueh, M. Yamoto, 1990, Endocrinology.

Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response.

P. Devroey, A. Zandvliet, B. Fauser, 2011, Reproductive biomedicine online.

A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.

P. Devroey, B. Fauser, J. Tapanainen, 2008, Human reproduction.

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization.

P. Devroey, P. Platteau, B. Fauser, 2003, Fertility and sterility.

Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.

B. Fauser, Z. Shoham, N. Lahlou, 1996, Fertility and sterility.

Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.

B. Fauser, Z. Shoham, N. Lahlou, 1994, Human reproduction.

Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers.

B. Fauser, Z. Shoham, H. C. Coelingh Bennink, 1998, Fertility and sterility.

Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.

S. Lamberts, B. Fauser, H. C. Coelingh Bennink, 1992, The Journal of clinical endocrinology and metabolism.

Interference with follicle stimulating hormone regulation of human ovarian function.

B. Fauser, 1996, Molecular human reproduction.

Indications for IVF treatment: from diagnosis to prognosis

B. Fauser, N. Macklon, 2004 .

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol

P. Devroey, B. Fauser, R. Boostanfar, 2009, Human reproduction.

Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome

B. Fauser, P. Donderwinkel, H. Bennink, 1992, The Lancet.

Expression of biologically active human follitropin in Chinese hamster ovary cells.

M. Matzuk, B. Fauser, A. Hsueh, 1989, The Journal of biological chemistry.

A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone.

I. Huhtaniemi, R. Clayton, B. Fauser, 1999, The Journal of clinical endocrinology and metabolism.

Bioassays of gonadotropins.

B. Fauser, S. Christin‐Maitre, P. Bouchard, 2000, Methods.

Long‐Term, Pulsatile, Low Dose, Subcutaneous Luteinizing Hormone‐Releasing Hormone Administration in Men with Idiopathic Oligozoospermia Failure of Therapeutic and Hormonal Response

B. Fauser, J. Dony, R. Rolland, 2009, Andrologia.

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.

B. Fauser, S. Nelson, A. Nyboe Andersen, 2017, Fertility and sterility.

Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation

B. Fauser, H. C. Coelingh Bennink, H. Out, 1998, Fertility and sterility.

Molecular biology in reproductive medicine

B. Fauser, 1999 .

Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF.

C. Wijmenga, L. Franke, F. Broekmans, 2011, Reproductive biomedicine online.

disorders: Part I: polycystic ovary syndrome

B. Destenaves, B. Fauser, M. Simoni, 2008 .

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.

P. Devroey, B. Fauser, K. Diedrich, 2008, Human reproduction update.

Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years.

B. Fauser, F. de Jong, I. Schipper, 1998, Human reproduction.

Biennial review of infertility

C. Racowsky, B. Fauser, D. Carrell, 2009 .

Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.

A. Hofman, B. Fauser, J. Laven, 2009, Human reproduction.

Serum Hormone Concentrations During Treatment with Multiple Rising Doses of Recombinant Follicle-Stimulating Hormone (Puregon) in Men with Hypogonadotropic Hypogonadism

B. Fauser, Z. Shoham, N. Lahlou, 1998 .

Altered ovarian function and cardiovascular risk factors in valproate-treated women.

M. Knip, L. Gjerstad, H. Harbo, 2001, The American journal of medicine.

Single monthly administration of the anti-progestagen Org 31710 in users of the 75 microg desogestrel progestagen-only pill: effects on pituitary-ovarian activity.

B. Fauser, H. C. Coelingh Bennink, S. Killick, 2000, Human reproduction.

Differential effect of luteinizing hormone-releasing hormone infusion on testicular steroids in normal men and patients with idiopathic oligospermia.

B. Fauser, A. Smals, J. Dony, 1984, Fertility and sterility.

Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement†‡.

K. Barnhart, C. Farquhar, B. Fauser, 2014, Human reproduction.

Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging.

M. Eijkemans, B. Fauser, N. Macklon, 2002, Fertility and sterility.

Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle-stimulating hormone: the role of oestradiol.

B. Fauser, B. Fauser, 1997, Human reproduction update.

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.

F. Broekmans, B. Fauser, E. T. te Velde, 2002, Human reproduction.

Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways

Andrew D. Johnson, Yan V. Sun, Lorna M. Lopez, 2012, Nature Genetics.

Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways

Yan V. Sun, Lorna M. Lopez, E. Demerath, 2012, Nature Genetics.

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.

A. Zandvliet, B. Fauser, W. Schoolcraft, 2011, Reproductive biomedicine online.

Corifollitropin alfa followed by a low dose of rFSH or HCG to induce monofollicular growth in women with WHO group II anovulatory infertility; a pilot study

B. Fauser, N. Macklon, E. Heijnen, 2009 .

Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates.

R. Fanchin, B. Tarlatzis, B. Fauser, 2018, Human reproduction.

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.

A. Zandvliet, B. Fauser, W. Schoolcraft, 2011, Reproductive biomedicine online.

Gonadotropins in Polycystic Ovarian Syndrome

B. Fauser, F. H. Jong, F. Jong, 1993, Annals of the New York Academy of Sciences.

The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates *

W. Hop, B. Fauser, F. H. Jong, 1992 .

Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.

M. Eijkemans, F. Broekmans, B. Fauser, 2009, The Journal of clinical endocrinology and metabolism.

The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis

M. Eijkemans, M. Blankenstein, B. Fauser, 2013, Human reproduction update.

Contemporary genetic technologies and female reproduction

C. Simón, M. Matzuk, P. Devroey, 2011, Human reproduction update.

Heterozygosity for the Classical Galactosemia Mutation Does Not Affect Ovarian Reserve and Menopausal Age

M. Eijkemans, F. Broekmans, B. Fauser, 2007, Reproductive Sciences.

Polycystic ovaries in female-to-male transsexuals.

B. Fauser, T. Pache, 1993, Clinical endocrinology.

A role for Aurora C in the chromosomal passenger complex during human preimplantation embryo development.

H. Jahr, G. Kops, S. Lens, 2011, Human reproduction.

Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.

F. Broekmans, B. Fauser, J. Laven, 2014, Human reproduction update.

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome

D. Timmerman, B. Fauser, J. Laven, 2021, The Journal of clinical endocrinology and metabolism.

Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.

B. Fauser, N. Chabbert-Buffet, P. Bouchard, 2011, Fertility and sterility.

The impact of chronic endometritis on reproductive outcome.

P. Devroey, F. Broekmans, B. Fauser, 2011, Fertility and sterility.

Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene.

C. Wijmenga, L. H. van den Berg, M. V. van Es, 2009, Human reproduction.

The reliability of the histological diagnosis of endometritis in asymptomatic IVF cases: a multicenter observer study.

M. Eijkemans, P. Devroey, F. Broekmans, 2012, Human reproduction.

Developmental and endocrine aspects of normal ovarian aging

F. Broekmans, B. Fauser, E. T. te Velde, 1998, Molecular and Cellular Endocrinology.

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?

M. Eijkemans, B. Fauser, J. Laven, 2014, Fertility and sterility.

Pregnancy complications in women with polycystic ovary syndrome.

B. Fauser, N. Macklon, C. Boomsma, 2008, Seminars in reproductive medicine.

Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.

W. Hop, B. Fauser, F. de Jong, 1995, Fertility and sterility.

Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure.

R. Frydman, B. Donadille, N. Bourcigaux, 2009, The Journal of clinical endocrinology and metabolism.

Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids.

I. Osterloh, D. Barlow, B. Fauser, 2015, Fertility and sterility.

The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.

Y. T. van der Schouw, N. Onland-Moret, F. Broekmans, 2014, Human reproduction.

Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis

M. Eijkemans, C. Uiterwaal, A. Kunselman, 2019, Human reproduction update.

Drug-free in-vitro activation of ovarian cortex; can it really activate the 'ovarian gold reserve'?

B. Fauser, G. Griesinger, 2020, Reproductive biomedicine online.

Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF.

M. Eijkemans, B. Fauser, A. Kavelaars, 2009, Human reproduction.

Follicle pool depletion: factors involved and implications.

B. Fauser, 2000, Fertility and sterility.

A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer.

Marinus J C Eijkemans, J. Habbema, M. Eijkemans, 2002, Fertility and sterility.

What is the prognosis for a live birth after unexplained recurrent implantation failure following IVF/ICSI?

M. Eijkemans, M. Goddijn, B. Fauser, 2019, Human reproduction.

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.

J. Habbema, F. Broekmans, B. Fauser, 2005, Fertility and sterility.

Female reproductive ageing: current knowledge and future trends

F. Broekmans, B. Fauser, N. Macklon, 2007, Trends in Endocrinology & Metabolism.

The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age.

M. Blankenstein, F. Broekmans, B. Fauser, 2003, Human reproduction.

Observations in favor of normal early follicle development and disturbed dominant follicle selection in polycystic ovary syndrome.

B. Fauser, 1994, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Human studies on genetics of the age at natural menopause: a systematic review.

Y. T. van der Schouw, N. Onland-Moret, F. Broekmans, 2010, Human reproduction update.

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts.

M. Eijkemans, C. Lambalk, F. Broekmans, 2010, Human reproduction.

Renaming PCOS--a two-state solution.

B. Fauser, A. Dunaif, 2013, The Journal of clinical endocrinology and metabolism.

Reproductive characteristics of women diagnosed with premature ovarian insufficiency.

M. Eijkemans, F. Broekmans, B. Fauser, 2016, Reproductive biomedicine online.

Cumulative live birth rates following IVF in 41- to 43-year-old women presenting with favourable ovarian reserve characteristics.

M. Eijkemans, F. Broekmans, B. Fauser, 2007, Reproductive biomedicine online.

Birth defects and congenital health risks in children conceived through assisted reproduction technology (ART): a meeting report

R. Sharpe, P. Crosignani, L. Gianaroli, 2014 .

Determinants of future cardiovascular health in women with a history of preeclampsia.

A. Maas, A. Franx, C. D. de Groot, 2015, Maturitas.

Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.

A. Uitterlinden, L. Stolk, B. Fauser, 2013, The Journal of clinical endocrinology and metabolism.

Coronary artery calcification in middle‐aged women with premature ovarian insufficiency

A. Maas, A. Franx, M. Eijkemans, 2019, Clinical endocrinology.

Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-brain natriuretic peptide in postmenopausal women.

O. Franco, M. Ikram, M. Kavousi, 2018, International journal of cardiology.

Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF.

Marinus J C Eijkemans, M. Eijkemans, F. Broekmans, 2008, Fertility and sterility.

Transsphenoidal resection in Cushing's disease: definition of success

G. Chrousos, B. Fauser, T. Friedman, 1993, Clinical endocrinology.

Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis.

M. Eijkemans, B. Fauser, F. Janse, 2012, Human reproduction update.

Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

J. Habbema, M. Eijkemans, B. Fauser, 1998, The Journal of clinical endocrinology and metabolism.

Reprint of: Antimüllerian hormone serum levels: a putative marker for ovarian aging.

B. Fauser, J. Laven, F. de Jong, 2019, Fertility and sterility.

Basics of Ovarian Stimulation

F. Broekmans, B. Fauser, S. Tanahatoe, 2017 .

Hormone patterns after induction of ovulation with clomiphene citrate: an age-related phenomenon.

F. Broekmans, B. Fauser, E. T. te Velde, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Circulating Neutrophils Do Not Predict Subclinical Coronary Artery Disease in Women with Former Preeclampsia

A. Maas, A. Franx, H. D. den Ruijter, 2020, Cells.

A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix.

B. Fauser, N. Macklon, D. de Jong, 2000, Fertility and sterility.

Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome.

W. Hop, B. Fauser, F. de Jong, 1992, Fertility and sterility.

The Role of Gn-RH Antagonists in Supporting Ovarian Hyperstimulation Protocols

R. Frydman, B. Fauser, N. Chabbert-Buffet, 2003 .

Genetics: Genetic basis of human reproductive endocrine disorders

B. Fauser, A. Hsueh, 1995 .

Genetic basis of human reproductive endocrine disorders.

B. Fauser, A. Hsueh, 1995, Human reproduction.

Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.

A. Hofman, B. Fauser, J. Laven, 2011, Human reproduction.

Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.

O. Franco, M. Kavousi, F. Broekmans, 2015, Human reproduction.

Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective analysis of the Engage trial.

B. Fauser, M. Abuzeid, H. Witjes, 2014, Reproductive biomedicine online.

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).

M. Eijkemans, B. Fauser, H. C. Coelingh Bennink, 2001, Fertility and sterility.

Copy number variants on the X chromosome in women with primary ovarian insufficiency.

C. Wijmenga, K. Kok, H. Blauw, 2011, Fertility and sterility.

Early Onset of Coronary Artery Calcification in Women With Previous Preeclampsia

A. Maas, A. Franx, E. Boersma, 2020, Circulation. Cardiovascular imaging.

Diagnosis and management of the infertile couple: missing information.

E. Diczfalusy, B. Tarlatzis, D. Baird, 2004, Human reproduction update.

Menopause prediction and potential implications.

B. Fauser, N. Daan, 2015, Maturitas.

Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.

M. Eijkemans, B. Fauser, J. Laven, 2000, Human reproduction.

Estrogen deprivation and cardiovascular disease risk in primary ovarian insufficiency.

M. Eijkemans, C. Lambalk, B. Fauser, 2018, Fertility and sterility.

How to discriminate between normal and polycystic ovaries: transvaginal US study.

W. Hop, J. Wladimiroff, B. Fauser, 1992, Radiology.

Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk

A. Franx, B. Fauser, B. V. van Rijn, 2010, Menopause.

Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.

M. Eijkemans, F. Broekmans, B. Fauser, 2008, Human reproduction.

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome

J. Roos‐Hesselink, E. Boersma, M. Kavousi, 2019, Clinical Endocrinology.

Consensus on women's health aspects of polycystic ovary syndrome (PCOS).

Adam H. Balen, Robert W. Rebar, Felice Petraglia, 2012, Human reproduction.

Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.

B. Fauser, J. Laven, F. de Jong, 2005, European journal of endocrinology.

Introduction: optimal in vitro fertilization in 2020: the global perspective.

G. Serour, B. Fauser, 2013, Fertility and sterility.

Serum luteinizing hormone-releasing hormone (LH-RH) and gonadotropic hormones in men after a bolus dose of LH-RH: comparison of different doses and routes of administration.

B. Fauser, J. Dony, W. Doesburg, 1985, Fertility and sterility.

Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle.

J. Passchier, M. Eijkemans, B. Fauser, 2007, Human reproduction.

Safety after extended repeated use of ulipristal acetate for uterine fibroids

D. Barlow, B. Fauser, J. Donnez, 2017, PloS one.

Long-term medical management of uterine fibroids with ulipristal acetate.

D. Barlow, B. Fauser, H. Fernandez, 2016, Fertility and sterility.

Effectiveness of a psychosocial counselling intervention for first-time IVF couples: a randomized controlled trial.

J. Passchier, H. Duivenvoorden, B. Fauser, 2005, Human reproduction.

FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility.

M. Eijkemans, B. Fauser, N. Macklon, 2002, European journal of endocrinology.

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.

J. Itskovitz‐Eldor, B. Tarlatzis, P. Devroey, 1999, Human reproduction.

Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance.

Julie Brown, C. Farquhar, A. Lethaby, 2017, Reproductive biomedicine online.

Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.

B. Fauser, E. J. V. van Santbrink, E. V. van Santbrink, 1997, The Journal of clinical endocrinology and metabolism.

Gonadotropin Ovulation Induction

B. Fauser, N. Macklon, 2004 .

Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.

W. Hop, B. Fauser, F. de Jong, 1993, Acta endocrinologica.

Ef fi cacy and safety of repeated use of ulipristal acetate in uterine fi broids

Herv, I. Osterloh, D. Barlow, 2022 .

Endocrinology: Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist

W. Hop, B. Fauser, P. Donderwinkel, 1993 .

Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.

M. Eijkemans, C. Lambalk, F. Broekmans, 2013, Human reproduction.

Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6.

M. Eijkemans, C. Lambalk, F. Broekmans, 2013, Fertility and sterility.

New Approach to Polycystic Ovary Syndrome and Other Forms of Anovulatory Infertility

M. Eijkemans, B. Fauser, J. Laven, 2002, Obstetrical & gynecological survey.

Predictors of recovery of ovarian function during weight gain in anorexia nervosa.

M. Kas, H. van Engeland, M. Eijkemans, 2007, Fertility and sterility.

Associations of preconception Body Mass Index in women with PCOS and BMI and blood pressure of their offspring

M. Eijkemans, B. Fauser, B. V. van Rijn, 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Dynamics of Human Follicle Development

B. Fauser, T. Pache, D. Schoot, 1993 .

Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial.

J. Habbema, M. Eijkemans, B. Fauser, 2006, Human reproduction.

May the colleague who truly has no conflict of interest now please stand up!

B. Fauser, N. Macklon, 2019, Reproductive biomedicine online.

Lipid profile of women with premature ovarian failure

M. Eijkemans, Y. T. van der Schouw, B. Fauser, 2008, Menopause.

The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study

M. Ikram, M. Eijkemans, E. Boersma, 2020, PloS one.

Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.

M. Eijkemans, F. Broekmans, B. Fauser, 2007, Human reproduction.

Anti‐Müllerian hormone variability and its implications for the number of oocytes retrieved following individualized dosing with follitropin delta

B. Fauser, S. Nelson, A. Nyboe Andersen, 2019, Clinical endocrinology.

Future challenges for clinical embryologists.

L. Rienzi, B. Fauser, 2021, Reproductive biomedicine online.

Response from the Editors: time-lapse systems for ART - meta-analyses and the issue of bias.

B. Fauser, J. García-Velasco, M. Alikani, 2017, Reproductive biomedicine online.

Developments in human recombinant follicle stimulating hormone technology: are we going in the right direction?

B. Fauser, 1998, Human reproduction.

The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates.

W. Hop, B. Fauser, F. de Jong, 1993, Clinical endocrinology.

Genes involved in initial follicle recruitment may be associated with age at menopause.

Y. T. van der Schouw, N. Onland-Moret, F. Broekmans, 2011, The Journal of clinical endocrinology and metabolism.

The significance of fragile Xmental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency

N. Onland-Moret, F. Broekmans, B. Fauser, 2014 .

Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria.

M. Eijkemans, Zi-jiang Chen, B. Fauser, 2010, Reproductive biomedicine online.

High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2).

J. Habbema, M. Eijkemans, B. Fauser, 2003, Human reproduction.

The step-down protocol

B. Fauser, N. Macklon, 2003 .

The impact of self-reported ethnicity versus genetic ancestry on phenotypic characteristics of polycystic ovary syndrome (PCOS).

O. Lao, M. Kayser, B. Fauser, 2014, The Journal of clinical endocrinology and metabolism.

High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice.

M. Eijkemans, B. Fauser, S. M. Veltman-Verhulst, 2012, Fertility and sterility.

Effect of B vitamins and genetics on success of in-vitro fertilisation

B. Fauser, N. Macklon, J. Boxmeer, 2006, The Lancet.

Mono-ovulatory cycles: A key goal in profertility programmes

R. Fanchin, L. Gianaroli, E. Diczfalusy, 2003 .

Insulin-like growth factors and insulin-like growth factor binding proteins in androgen-dominant ovarian follicles from testosterone-treated female-to-male trans-sexuals.

L. Giudice, B. Fauser, Y. Chandrasekher, 1997, Fertility and sterility.

Next Steps Toward AMH as a Robust Biomarker for Assessing Ovarian Aging in Individual Women

B. Fauser, S. Nelson, 2020, The Journal of clinical endocrinology and metabolism.

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome.

Marinus J Eijkemans, M. Eijkemans, M. van Wely, 2006, Fertility and sterility.

High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization.

B. Fauser, H. C. Coelingh Bennink, N. Macklon, 1998, Human reproduction.

Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.

W. Hop, B. Fauser, F. de Jong, 1993, Human reproduction.

WHITE PAPER: Access to Care Summit

C. Farquhar, E. Adashi, B. Fauser, 2015 .

Effect of transforming growth factor-beta on human chorionic gonadotropin induced testosterone production by cultured rat testicular cells.

B. Fauser, A. Hsueh, 1988, Life sciences.

LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome

B. Fauser, J. Laven, A. Mulders, 2005, Journal of endocrinological investigation.

Predicting pregnancy in women with polycystic ovary syndrome.

M. Eijkemans, B. Fauser, 2009, The Journal of clinical endocrinology and metabolism.

Diagnosis of subtle ovulation disorders in subfertile women with regular menstrual cycles: cost-effective clinical practice?

B. Fauser, E. T. te Velde, H. Koppeschaar, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Chapter 132 – Female Infertility: Evaluation and Management

F. Broekmans, B. Fauser, 2016 .

Pituitary gonadotropin responses to different modes and doses of intravenous luteinizing hormone-releasing hormone administration in normal men.

B. Fauser, J. Dony, W. Doesburg, 1984, Fertility and sterility.

The effect of pulsatile and continuous intravenous luteinizing hormone-releasing hormone administration on pituitary luteinizing hormone and follicle-stimulating hormone release in normal men.

B. Fauser, J. Dony, W. Doesburg, 1983, Fertility and Sterility.

Effect of aromatase inhibition by delta 1-testolactone on basal and luteinizing hormone-releasing hormone-stimulated pituitary and gonadal hormonal function in oligospermic men.

B. Fauser, A. Smals, J. Dony, 1985, Fertility and sterility.

Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.

B. Fauser, A. Goverde, T. V. van Haeften, 2013, Human reproduction.

Trends in clinical reproductive medicine research: 10 years of growth.

C. Simón, B. Fauser, R. Aleixandre-Benavent, 2015, Fertility and sterility.